SCHEMBL5468508

SCHEMBL5468508

Cc1cccc2c(Cl)c3c(C)nn(C)c3nc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 2/20 0.38
RAD52 P43351 1/20 0.38
KDM4E B2RXH2 8/20 0.38
HSD17B10 Q99714 5/20 0.38
CASP1 P29466 4/20 0.38
CASP7 P55210 4/20 0.38
MAPT P10636 3/20 0.38
NR3C1 P04150 2/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
GLA P06280 1/20 0.37
ALDH1A1 P00352 3/20 0.37
HCRTR1 O43613 1/20 0.36
HSP90AB1 P08238 1/20 0.36
HPGD P15428 2/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5467801 0.80 ALDH1A1 (0.42) MEN1KMT2AGAAKDM4EMAPT
SCHEMBL5307603 0.79 MAOA (0.47) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL6350556 0.78 KDM4E (0.38) RAB9AMEN1KMT2ARAD52KDM4E
SCHEMBL6341358 0.77 KDM4E (0.41) RAB9AMEN1KMT2AGAAKDM4E
SCHEMBL6344619 0.76 KDM4E (0.36) MEN1KMT2AGAARAD52KDM4E
SCHEMBL6342644 0.75 KDM4E (0.38) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL6343129 0.75 CCNA2 (0.38) MEN1KMT2AGAARAD52KDM4E
SCHEMBL6339835 0.72 KDM4E (0.37) MEN1KMT2AGAAKDM4EHSD17B10
SCHEMBL2125784 0.71 KDM4E (0.49) MEN1KMT2AGAARAD52KDM4E
SCHEMBL5471087 0.71 MEN1 (0.45) MEN1KMT2ARAD52KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070253957-A1 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis CYTOVIA, INC. (US) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070253957-A1 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis CASP3, CASP7, CASP4 NPC1 2592/4885RAB9A 594/4885MEN1 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.